Nigel Bark, Nicholas Lawson, Eileen Trigoboff, Rodica Varadi, Jeffery Grace, Josie Olympia, Nighat Sindhu, Tom Watson, Mohamed El-Defrawi, Punyabrata Roy
So far, demographic variables have not consistently been found to predict clinical response to antipsychotics. This study examines some differences in response to ziprasidone, which has been shown to be effective, with a better metabolic side effect profile, but was little used in New York State Hospitals. The aim was to study state hospital patients switched to ziprasidone. The results led to questions about different responses in different groups. Subjects from state hospitals who needed a change of antipsychotic participated in this open-label, 8-week trial of up to 240-mg ziprasidone...
2018: Clinical Schizophrenia & related Psychoses